Psychiatry Explored

Join us in the second half of our discussion with Dr. Aryan Sarparast and clinical researcher Will Lucas. This episode primarily discusses the practice of psychedelic integration.Articles, Books and other Resources: Hu X, Gorman I, Nielson E. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Curr Top Behav Neurosci. 2026;77:397-416. doi: 10.1007/7854_2024_529. PMID: 39654004.Examples of Psychedelic Integration Trainings: CIIS, IPI, FLUENCE, TCAL, PCAL Moezzi, Melody. The Rumi Prescription: How an Ancient Mystic Poet Changed My Modern Manic Life. TarcherPerigee, 2020. [1]Grof, Stanislav. The Way of the Psychonaut: Stanislav Grof's Journey of Consciousness. Multidisciplinary Association for Psychedelic Studies (MAPS), 2019. [1, 2]The Shulgin Foundation: https://shulginfoundation.orgWomen's Visionary Council: https://visionarycongress.org

Join us as we begin our two part discussion of Psychedelic Assisted Psychotherapy and Integration with Dr. Arayan Sarparast of the OHSU Psilocybin Education & Assessment Collaborative for Excellence (PEACE) Clinic and clinical research coordinator Will Lucas. This episode focuses primarily on counseling patients interested in Psychedelic Assisted Psychotherapy and harm reduction strategies when working with patients that have presented to the hospital with altered mental status after ingesting Psychedelic substances. We also discuss medico-legal issues surrounding psilocybin, primarily in the state of Oregon. Stay tuned for part 2 in which we will further dive into integration and psychotherapy after psychedelic experiences. Additional learning materials and resources for this episode can be found at: About Oregon Psilocybin Services:⁠https://www.oregon.gov/oha/ph/preventionwellness/pages/oregon-psilocybin-services.aspx⁠Kelan L. Thomas, B.E.S. Robert Jesse, Nicky J. Mehtani, Jennifer M. Mitchell & Brian T. Anderson (2023): Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics, Journal of Psychoactive Drugs, DOI: 10.1080/02791072.2023.2201244Bathje GJ, Majeski E and Kudowor M (2022) Psychedelic integration: An analysis of the concept and its practice.Front. Psychol. 13:824077. doi: 10.3389/fpsyg.2022.824077Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268-1278.For any questions and feedback, please contact us at [email protected].

Join us for a fascinating conversation about delirium work up and management in a primarily inpatient setting with OHSU consult liaison psychiatrists Dr. Kamalika Roy and Dr. Jonathan Floriani.

Dive into an informative conversation with Developmental and Behavioral Pediatricians Dr. Randall Phelps & Dr. Amelia Roth as we discuss multimodal evaluation for Autism Spectrum Disorder in children, as well as existing supports for patients with ASD and their families and further psychiatric considerations for neurodiverse youth. As a note, we acknowledge that ASD does not solely affect children as more and more individuals are being diagnosed at older ages, partly due to systemic injustice in the medical system. The scope of this episode is limited to workup in a pediatric population. Hosted by Maya Singh Sharkey (she/her) and Harland Harrison (they/them)Questions? Reach out to us at: [email protected]

Join us as psychiatrists Dr. Julie Anderson and Dr. Sean Stanley unravel the complexities of Bipolar Disorder. In the second and final part of our series on mood disorders, they discuss the diagnosis of Bipolar disorder, including the distinctions between Bipolar I and II,  as well as pharmacologic and psychosocial therapies for patients with bipolar disorder. This discussion of Bipolar disorder is ideal for medical learners, physicians, and anyone curious about the subject. We will be discussing manic, hypomanic, and major depressive episodes in our discussion of Bipolar Disorders. Full diagnostic criteria for those episodes can be found in Section 2 of the DSM-V under Bipolar and related disorders. References: 1. The Sydney Bipolar Screener 2. VVA/DOD Clinical Practice Guidelines for Management of Bipolar Disorder 3. National Collaborating Centre for Mental Health (UK). Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. London: The British Psychological Society and The Royal College of Psychiatrists; 2014 Sep. PMID: 29718639. (2014, some updates 2023)  4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170.